Sandoz Group AG said Europe’s medicines regulator is proposing to pull amoxicillin from its list of critical medicines, a potential death blow to the last European factory to make the antibiotic from scratch.
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.